Cart
sales@molnova.com
Home - Products - Metabolic Enzyme/Protease - PPAR - WY-14643 (Pirinixic Acid)

WY-14643 (Pirinixic Acid)

CAS No. 50892-23-4

WY-14643 (Pirinixic Acid)( Pirinixic Acid )

Catalog No. M14744 CAS No. 50892-23-4

WY 14643 (Pirinixic Acid) is a potent peroxisome proliferator and activator of PPARα with EC50 of 1.5 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 37 In Stock
50MG 65 In Stock
100MG 96 In Stock
200MG 136 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    WY-14643 (Pirinixic Acid)
  • Note
    Research use only, not for human use.
  • Brief Description
    WY 14643 (Pirinixic Acid) is a potent peroxisome proliferator and activator of PPARα with EC50 of 1.5 μM.
  • Description
    WY 14643 (Pirinixic Acid) is a potent peroxisome proliferator and activator of PPARα with EC50 of 1.5 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Pirinixic Acid
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPARα
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    50892-23-4
  • Formula Weight
    323.8
  • Molecular Formula
    C14H14ClN3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 52 mg/mL (160.59 mM); DMSO: 65 mg/mL (200.74 mM)
  • SMILES
    O=C(O)CSC1=NC(NC2=CC=CC(C)=C2C)=CC(Cl)=N1
  • Chemical Name
    [[4-chloro-6-[(2,3-dimethylphenyl)amino]-2-pyrimidinyl]thio]-acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Issemann I, et al. Nature. 1990, 347(6294), 645-650. 2. Staels B, et al. Nature. 1998, 393(6687), 790-793.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Fucosterol

    Fucosterol is isolated from E. stolonifera with anti-diabetic anti-adipogenic and anti-cancer activities. It regulates adipogenesis via modulation of PPARα and C/EBPα expression.

  • CGS 15435

    CGS 15435 is a potent thromboxen (TxA2) synthetase inhibitor (IC50: 1 nM). CGS 15435 acts on PGI2 synthase, cyclooxygenase and liposynthase with much less selectivity than on thromboxin synthase.

  • Muraglitazar

    Muraglitazar (BMS-298585) is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia.

Sign In Join Free